PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy

PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy

Abstract Background The prostate-specific membrane antigen (PSMA) is a relevant target in prostate cancer, and immunohistochemistry studies showed associations with outcome. PSMA-ligand positron emission tomography (PET) is increasingly used for primary prostate cancer staging, and the molecular ima...

Full description

Bibliographic Details
Main Authors: Hui Wang, Thomas Amiel, Christoph Würnschimmel, Thomas Langbein, Katja Steiger, Isabel Rauscher, Thomas Horn, Tobias Maurer, Wolfgang Weber, Hans-Juergen Wester, Karina Knorr, Matthias Eiber
Format: Article
Language:English
Published: SpringerOpen 2021-08-01
Series:EJNMMI Research
Subjects:
Biochemical recurrence
68Ga-PSMA-11 PET
miTNM classification
Prostate cancer
Online Access:https://doi.org/10.1186/s13550-021-00818-2

Internet

https://doi.org/10.1186/s13550-021-00818-2

Similar Items